A Personalized Approach to Better Liver Health

Hepatitis B is common, but it should not always be considered the same for everyone who has it. In some people, the infection remains inactive for decades with minimal impact on the liver, while in others it can progress quietly to fibrosis, cirrhosis and, in advanced cases, liver cancer.

Hepatitis B is generally described in two forms: acute infection, which many healthy adults clear on their own, and chronic infection, which persists beyond six months and requires structured, long-term care. Within chronic infection, doctors also look closely at whether the virus is currently active or inactive, since this changes the management plan considerably.

At the practice of Dr. Ashok Choudhury, Hepatitis B management focuses on understanding the phase of infection, assessing the true condition of the liver, addressing risk to family members, and creating a practical, long-term plan for each patient.

Hepatitis B Is Manageable

The right approach can make a meaningful difference

A positive Hepatitis B test does not automatically mean that liver damage has occurred or that treatment is needed immediately.

The next step is to understand:

• Whether the infection is acute or chronic
• Whether the virus is actively replicating
• Whether liver inflammation or fibrosis is present
• Whether family members or partners need testing or vaccination
• Whether pregnancy planning requires additional precautions
• Whether the liver needs active treatment now or ongoing monitoring instead
• Whether coinfection with Hepatitis D is a relevant consideration

The goal is not simply to “detect the virus”. It is to understand its behaviour in your body and protect your liver over the long term.

Our Approach to Hepatitis B Management

1. Understand the Phase of Infection

Chronic Hepatitis B moves through recognised phases, and treatment decisions depend heavily on which phase a patient is in.

Assessment may include looking at:

• Viral activity (HBV DNA) Measuring how actively the virus is replicating helps determine whether treatment is currently needed.
• HBeAg status This marker helps classify the phase of infection and guides the monitoring schedule.
• Liver enzyme trends Enzyme levels over time reveal whether the liver is currently under active stress from the virus.
• Family and transmission history Understanding how and when infection may have occurred helps assess risk to others.
• Coinfections Testing for Hepatitis D and, where relevant, HIV is an important part of a complete assessment.

2. Assess the Liver Properly

Many people with chronic Hepatitis B feel entirely well, even when the liver has sustained meaningful damage. Assessing the liver directly is therefore essential, not optional.

Depending on the individual patient, assessment may include:

• Liver Blood Tests To evaluate liver enzymes and other markers of liver health over time.
• Ultrasound Used to assess liver structure and screen for early signs of complications.
• FibroScan A non-invasive test that helps assess liver stiffness, an indicator of fibrosis.
• Fibrosis Risk Assessment Non-invasive scores help identify patients who need closer monitoring or further evaluation, in line with AASLD guidance on staging chronic Hepatitis B.
• Liver Cancer Screening Regular imaging and blood markers are used to screen for hepatocellular carcinoma in patients at higher risk, particularly those with cirrhosis or a strong family history.

3. Treatment and Ongoing Monitoring

Not every patient with chronic Hepatitis B needs immediate medication. The decision is individualised, based on viral activity, liver damage and other risk factors.

• Antiviral therapy Medications such as tenofovir and entecavir suppress viral replication and significantly reduce the risk of cirrhosis and liver cancer when treatment is indicated.
• Structured monitoring For patients not yet needing treatment, regular bloodwork and imaging track the infection closely so that treatment can begin promptly if the picture changes.
• Pregnancy planning Additional monitoring and, where appropriate, antiviral therapy help protect both mother and baby and prevent transmission at birth.
• Long-term follow-up Because chronic Hepatitis B is a long-term condition, care is structured around consistent, scheduled review rather than a single visit.

4. Protect Family Members and Reduce Long-Term Risk

Hepatitis B management extends beyond the individual patient to the people closest to them.

• Vaccination for contacts Household members and partners who are not immune are offered vaccination to prevent transmission.
• Newborn protection Babies born to mothers with Hepatitis B can receive a vaccine dose and immune globulin within hours of birth, dramatically reducing transmission risk.
• Lifestyle guidance Avoiding alcohol, discussing new medications and supplements before starting them, and maintaining a healthy weight all help protect a liver already managing chronic infection.
• Hepatitis A vaccination Patients with chronic Hepatitis B are generally advised to be vaccinated against Hepatitis A, since a second liver infection carries added risk.

Living With Chronic Hepatitis B

A chronic Hepatitis B diagnosis is not a diagnosis of inevitable liver disease. With regular monitoring, and treatment when it is genuinely indicated, most patients live long, full lives with well-preserved liver function. The emphasis at every stage is on understanding your specific phase of infection, rather than applying a generic plan to every patient.

A Personalized Plan, Not a One-Size-Fits-All Answer

Hepatitis B behaves differently in different people, which is why staging the infection accurately matters so much. At the practice of Dr. Ashok Choudhury, care is built around a clear picture of your viral activity, liver health and personal risk factors, with a monitoring or treatment plan designed specifically for you.

If you have been diagnosed with Hepatitis B, or have never been tested and want clarity on your status, a consultation is the right first step toward a plan built around your liver, not a generic protocol.